Context Clinical surveys have revealed that incidental detection of renal c
ell carcinoma is rising because of increased use of imaging procedures.
Objective To examine incidence, mortality, and survival trends of renal cel
l and renal pelvis cancers by age, sex, race, and tumor stage at diagnosis,
Design Calculation of age-adjusted incidence and mortality rates, along wit
h 5-year relative survival rates, using data from the National Cancer Insti
tute's Surveillance, Epidemiology, and End Results (SEER) program.
Setting and Participants Patients diagnosed as having kidney cancer from 19
75 through 1995 in the 9 geographic areas covered by tumor registries in th
e SEER program, which represent about 10% of the US population.
Main Outcome Measures Incidence, mortality, and 5-year relative survival ra
tes by time periods,
Results The age-adjusted incidence rates for renal cell carcinoma between 1
975 and 1995 for white men, white women, black men, and black women were 9.
6, 4.4, 11.1, and 4.9 per 100 000 person-years, respectively. The correspon
ding rates for renal pelvis cancer were 1.5, 0.7, 0.8, and 0.5 per 100 000
person-years, Renal cell cancer incidence rates increased steadily between
1975 and 1995, by 2.3% annually among white men, 3.1% among white women, 3.
9% among black men, and 4.3% among black women. Increases were greatest for
localized tumors but were also seen for more advanced and unstaged tumors.
In contrast, the incidence rates for renal pelvis cancer declined among wh
ite men and remained stable among white women and blacks. Although 5-year r
elative survival rates for patients with renal cell cancer improved among w
hites but not among blacks, kidney cancer mortality rates increased in all
race and sex groups.
Conclusions Increasing detection of presymptomatic tumors by imaging proced
ures, such as ultrasonography, computed tomography, and magnetic resonance
imaging, does not fully explain the upward incidence trends of renal cell c
arcinoma. Other factors may be contributing to the rapidly increasing incid
ence of renal cell cancer in the United States, particularly among blacks.